UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000063455
Receipt number R000071901
Scientific Title Effects of a Husband-Involved mHealth Intervention on Postpartum Depressive Symptoms, Anxiety, and Mother-Infant Bonding Among Postpartum Women in Rural Bangladesh: A Randomized Controlled Trial
Date of disclosure of the study information 2026/10/29
Last modified on 2026/10/29 10:28:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of mHealth Intervention on Postpartum Depressive Symptom, Anxiety, and Maternal-Infant Bonding Among the Postpartum Women in Rural Community of Bangladesh: A Randomized Controlled Trial

Acronym

Husband-Involved Postpartum mHealth Study

Scientific Title

Effects of a Husband-Involved mHealth Intervention on Postpartum Depressive Symptoms, Anxiety, and Mother-Infant Bonding Among Postpartum Women in Rural Bangladesh: A Randomized Controlled Trial

Scientific Title:Acronym

SMART-MAMA-BG Trial

Region

Asia(except Japan)


Condition

Condition

Postpartum depressive symptoms

Classification by specialty

Obstetrics and Gynecology Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of an mHealth intervention with husband involvement on reducing postpartum depressive symptoms and anxiety and improving mother-infant bonding among postpartum women in rural Bangladesh, to evaluate women's knowledge, attitudes, and practices regarding infant positioning and attachment during breastfeeding, and to explore postpartum women's and husbands' experiences and perceptions of the mHealth intervention and barriers and facilitators affecting postpartum mental health.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Change in postpartum depressive symptoms measured by the Edinburgh Postnatal Depression Scale (EPDS) from baseline to the end of the 12-week intervention.

Key secondary outcomes

1. Change in anxiety measured by the State-Trait Anxiety Inventory (STAI) from baseline to the end of the 12-week intervention.
2. Change in mother-infant bonding measured by the Mother and Infant Bonding Score (MIBS) from baseline to the end of the 12-week intervention.
3. Change in women's knowledge, attitudes, and practices (KAP) regarding infant positioning and attachment during breastfeeding from baseline to the end of the 12-week intervention.
4. Postpartum women's and husbands' experiences and perceptions of the mHealth intervention and barriers and facilitators affecting postpartum mental health.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

In addition to routine postnatal care, participants in the intervention group will receive a 12-week mHealth education intervention using a mobile application. The intervention includes physical support (stretching and pelvic floor muscle training), psychological support (muscle relaxation and breathing techniques), and education on postpartum depression, self-care, mother-infant bonding, breastfeeding, and infant positioning and attachment during breastfeeding. Daily push notifications will be provided, and application use and learning progress will be recorded. Husbands will receive orientation and counseling and will be encouraged to provide psychological and practical support, participate in household and childcare activities, and support the women's use of the application.

Interventions/Control_2

Participants in the control group will receive routine postnatal care in accordance with the national guidelines of Bangladesh. No additional mHealth education intervention will be provided during the study period. After completion of the endline assessment, health education materials will be provided to the control group.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. Postpartum women aged 18 years or older, either primiparous or multiparous, who delivered at full term.
2. Within 4 weeks postpartum at the time of study enrollment.
3. Residing in the study area for at least 6 months.
4. Able to use a smartphone or having regular access to an internet-enabled smartphone.
5. Willing to participate voluntarily and able to provide written informed consent.
6. Having mild (EPDS score 10-12) or moderate (EPDS score 13-18) depressive symptoms as assessed using the Edinburgh Postnatal Depression Scale (EPDS).
7. Living with their husband.

Key exclusion criteria

1. Participants with no postpartum depressive symptoms (EPDS score <10) or severe postpartum depressive symptoms (EPDS score >18).
2. Participants with a previous diagnosis of a mental disorder, such as psychosis or bipolar disorder.
3. Participants with serious health problems, such as chronic diseases.
4. Participants with disabilities or autism, or those who delivered a newborn with an apparent congenital anomaly.
5. Participants who may move out of the study area during the study period.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Yoko
Middle name
Last name Shimpuku

Organization

Hiroshima University

Division name

Graduate School of Biomedical and Health Sciences Program of Health Sciences

Zip code

734-8553

Address

1 Chome-2-3 Kasumi, Minami Ward, Hiroshima, Japan

TEL

082-257-5555

Email

yokoshim@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Bilkis
Middle name
Last name Banu

Organization

Independent University, Bangladesh

Division name

Department of Public Health, School of Pharmacy and Public Health

Zip code

1245

Address

Plot 16, Block B, Aftabuddin Ahmed Road, Bashundhara Residential Area, Bangladesh

TEL

8801716245245

Homepage URL


Email

bilkis@iub.edu.bd


Sponsor or person

Institute

Independent University, Bangladesh

Institute

Department

Personal name

Bilkis Banu


Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3 Minami-Ku, Hiroshima

Tel

082-257-1947

Email

iryo-sinsa@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2026 Year 08 Month 29 Day

Date of IRB

2026 Year 10 Month 28 Day

Anticipated trial start date

2026 Year 11 Month 01 Day

Last follow-up date

2027 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 10 Month 29 Day

Last modified on

2026 Year 10 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071901